MedTrace Logo

To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets

NCT02205151 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2014-10-15

No results posted yet for this study

Summary

An Open-label, Randomized, Single-dose, 2×2 Crossover Study to Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets in Healthy Male Volunteers

Conditions

Interventions

DRUG

Fimasartan

DRUG

Amlodipine

DRUG

Fimasartan/Amlodipine combination

Sponsors & Collaborators

  • Kyunghee university hospital A Drug Analytical Laboratory

    collaborator UNKNOWN

  • Boryung Pharmaceutical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • seunghoon han, M.D., Ph.D. · The Catholic university St. Mary hospital

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02205151 on ClinicalTrials.gov